Loading clinical trials...
Loading clinical trials...
The aim of the non-interventional study is to document the daily doses in acute and remission therapy, the frequence of doses (1, 2, 3 or 4 times daily), when rectal dosage forms are added and, when a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ferring Pharmaceuticals
Collaborators
NCT07550673 · Acute Severe Ulcerative Colitis
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07374471 · Ulcerative Colitis (UC)
NCT05739864 · Active Ulcerative Colitis
NCT06071312 · Clostridium Difficile, Ulcerative Colitis
Investigational , Karlsplatz 18
Aalen
Investigational Site, Goethestraße 5
Ansbach
Investigational Site, Elisenstraße 32
Aschaffenburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions